Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers.

Int J Mol Sci · 2023 · PMC9916805 · PMID 36768291

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendp = 0.059so close (0.05 < p ≤ 0.1)

Moreover, ovarian cancers that were triply positive for intraepithelial CD4 + , FOXP3 + , and CD25 + cells showed a trend towards increased survival ( p = 0.059) [ 55 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.